Anti-Human CD279 Recombinant Antibody(Cemiplimab)

Product Information

Catalog Number	YR1516
Product Name	Anti-Human CD279 Recombinant Antibody(Cemiplimab)
Molecular Name	Cemiplimab
Alias	Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab
CAS Number	1801342-60-8
Target	CD279[Homo sapiens]
Isotype	IgG4 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price